EUVIMEDEUVIMED entdecken
Crossref

Endoplasmic Reticulum-Targeted Biomimetic Nanoparticles Potentiate the Immunotherapy of Triple-Negative Breast Cancer by Improving Immunogenicity and Eliminating Immune Resistance

Shangui Liu, Cheng Zhang, Qixiang Feng, Jianbo Ji, Yuewu Xie, Yi Hao iD, Hailong Wang iD, Haining Tan iD, Guangxi Zhai iD

ACS Nano · 2026

DOI: 10.1021/acsnano.5c19913 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, 2026. Verfasst von Shangui Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, Key Laboratory of Chemical Biology (Ministry of Education), NMPA Key Laboratory for Technology Research and Evaluation o…. Hauptthemen laut MEDLINE: Immunotherapy, Nanoparticles, Triple Negative Breast Neoplasms, Endoplasmic Reticulum. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province, Program for Excellent Sci-tech Innovation Teams of Universities in Anhui Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyNanoparticlesTriple Negative Breast NeoplasmsEndoplasmic ReticulumBiomimetic MaterialsAntineoplastic AgentsAnimalsFemaleHumansMiceCell Line, TumorChlorophyllidesPorphyrins

Stichwörter der Autor:innen

cancer immunotherapyendoplasmic reticulum; cholesterol metabolismimmune resistanceimmunogenic cell death

Substanzen

ChlorophyllidesphytochlorinAntineoplastic AgentsPorphyrins

Autor:innen und Institutionen

  • Department of Pharmaceutics, Key Laboratory of Chemical Biology (Ministry of Education), NMPA Key Laboratory for Technology Research and Evaluation of Drug Products, School of Pharmaceutical Sciences, Cheeloo College of…
  • National Glycoengineering Research Center, Shandong University, Qingdao, Shandong 266237, China.
  • School of Pharmacy, Wannan Medical College, Wuhu 241002, China.
  • State Key Laboratory of Microbial Technology, Shandong University, Qingdao 266237 China.
  • NMPA Key Laboratory for Quality Research and Evaluation of Carbohydrate-Based Medicine, Shandong University, Qingdao 266237, China.
  • Shandong Freda Pharmaceutical Group Co. Ltd., Jinan 250101, China.

ORCID-Profile: Yi Hao, Hailong Wang, Haining Tan, Guangxi Zhai

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Shandong Province
  • Program for Excellent Sci-tech Innovation Teams of Universities in Anhui Province
  • State Key Laboratory of Microbial Technology
  • Shandong Provincial Program of Taishan Industrial Experts
  • National Science and Technology Major Special Project- Major New Drug Creation

Zitieren

APA

Liu, S., Zhang, C., Feng, Q., Ji, J., Xie, Y., Hao, Y., Wang, H., Tan, H., & Zhai, G. (2026). Endoplasmic Reticulum-Targeted Biomimetic Nanoparticles Potentiate the Immunotherapy of Triple-Negative Breast Cancer by Improving Immunogenicity and Eliminating Immune Resistance. ACS Nano. https://doi.org/10.1021/acsnano.5c19913

Vancouver

Liu S, Zhang C, Feng Q, Ji J, Xie Y, Hao Y, et al. Endoplasmic Reticulum-Targeted Biomimetic Nanoparticles Potentiate the Immunotherapy of Triple-Negative Breast Cancer by Improving Immunogenicity and Eliminating Immune Resistance. ACS Nano. 2026. doi:10.1021/acsnano.5c19913

BibTeX
@article{Liu2026,
  author = {Liu, Shangui and Zhang, Cheng and Feng, Qixiang and Ji, Jianbo and Xie, Yuewu and Hao, Yi and Wang, Hailong and Tan, Haining and Zhai, Guangxi},
  title = {Endoplasmic Reticulum-Targeted Biomimetic Nanoparticles Potentiate the Immunotherapy of Triple-Negative Breast Cancer by Improving Immunogenicity and Eliminating Immune Resistance},
  journal = {ACS Nano},
  year = {2026},
  doi = {10.1021/acsnano.5c19913}
}
Kostenlos starten →